跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,599 条关于
“MOTS-c”
全部
14,599
临床试验
7,431
药物
1,757
机构
3,024
资讯
2,387
上个月
FDA Advisory Committee Votes Against Compounding Emideltide, Citing Safety and Efficacy Concerns
5个月前
Fifty 1 Labs Advances AI-Powered Peptide Biotechnology Platform Targeting Musculoskeletal Health
3个月前
Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptides, Reports Formulation Progress Across BPC-157, Retatrutide, and Others
去年
Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement
去年
NIH to Sponsor Phase 1 Trial of Fzata's Novel Oral Biologic FZ002 for C. difficile Treatment
去年
HepaRegeniX Secures €15 Million to Advance HRX-215 for Liver Regeneration
去年
Key Infectious Disease Updates: C. difficile, Salmonella Outbreak, Hepatitis C Treatment, and More
2年前
ArsenalBio Secures $325 Million in Series C Funding to Advance CAR T-Cell Therapies for Solid Tumors
第 1 页,共 239 页
上一页
下一页